FUCILE, SERENA
FUCILE, SERENA
Universita' degli Studi di MILANO
Comparison of the ARK Immunoassay With High-Performance Liquid Chromatography With Ultraviolet Detection for Therapeutic Drug Monitoring of Linezolid
2018 S. Castoldi, V. Cozzi, S. Baldelli, S. Fucile, E. Clementi, D. Cattaneo
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients : an observational study in real-life settings
2016 M. Pozzi, D. Cattaneo, S. Baldelli, S. Fucile, A. Capuano, C. Bravaccio, L. Sportiello, S. Bertella, F. Auricchio, R. Bernardini, C. Ferrajolo, G. Guastella, E. Mani, C. Carnovale, S. Pisano, C. Rafaniello, M.P. Riccio, R. Rizzo, M.G. Scuderi, S. Sperandeo, L. Villa, A. Pascotto, M. Molteni, F. Rossi, S. Radice, E. Clementi
Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers : a randomized, open-label, 2-period, single-dose, crossover phase 1 study
2015 D. Cattaneo, M.V. Cossu, S. Fucile, A. Riva, S. Baldelli, P. Meraviglia, S. Landonio, C. Impagnatiello, C. Resnati, M. Galli, E. Clementi, A. Capetti, G. Rizzardini, C. Gervasoni
Comparison of the QMS® analyzer with HPLC-UV for the quantification of lamotrigine concentrations in human plasma samples
2015 S. Baldelli, S. Castoldi, N. Charbe, V. Cozzi, S. Fucile, D. Cattaneo, E. Clementi
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers
2014 M.V. Cossu, D. Cattaneo, S. Fucile, P. Pellegrino, S. Baldelli, V. Cozzi, A. Capetti, E. Clementi
Lights and shadows of the actual European guidelines on bioanalytical method validation : the case of raltegravir
2014 S. Baldelli, D. Cattaneo, S. Fucile, E. Clementi
Is it time to revise antiretrovirals dosing? : a pharmacokinetic viewpoint
2014 D. Cattaneo, S. Baldelli, S. Castoldi, N. Charbe, V. Cozzi, S. Fucile, E. Clementi
Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections
2013 D. Cattaneo, G. Orlando, V. Cozzi, L. Cordier, S. Baldelli, S. Merli, S. Fucile, C. Gulisano, G. Rizzardini, E.G.I. Clementi
Limited sampling strategies for the estimation of atazanavir daily exposure in HIV-infected patients
2013 D. Cattaneo, D. Ripamonti, S. Baldelli, V. Cozzi, S. Fucile, E. Clementi
Limited Sampling Strategies for the Estimation of Raltegravir Daily Exposure in HIV-Infected Patients
2012 D. Cattaneo, D. Ripamonti, C. Gervasoni, S. Landonio, P. Meraviglia, S. Baldelli, V. Cozzi, S. Fucile, E. Clementi
Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients
2012 D. Cattaneo, C. Gervasoni, V. Cozzi, S. Baldelli, S. Fucile, P. Meraviglia, S. Landonio, G. Boreggio, G. Rizzardini, E.G.I. Clementi